Incidence of tolerance, dependence, drug abuse and misuse of Targin in patients with Restless Legs Syndrome

Study identification

• EU PAS number:
  EUPAS41097
• Study ID:
  41661
• Official title and acronym:
  Incidence of tolerance, dependence, drug abuse and misuse of Targin in patients with Restless Legs Syndrome
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study status:
  Finalised

Research institutions and networks

Institutions

Institute for Applied Health Research Berlin (InGef)

Germany

Study timelines

Date when funding contract was signed

Planned:28/02/2018

Actual:28/02/2018

Study start date

Planned:01/10/2020

Actual:01/10/2020

Date of final study report

Planned:29/03/2021

Actual:29/03/2021

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Mundipharma

Regulatory

• Was the study required by a regulatory body?:
  Unknown
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable